Host and viral determinants of Mx2 antiretroviral activity
about
Impact of TRIM5α in vivoMisdelivery at the Nuclear Pore Complex-Stopping a Virus Dead in Its TracksEvolutionary Analyses Suggest a Function of MxB Immunity Proteins Beyond Lentivirus RestrictionThe KT Jeang Retrovirology prize 2015: Paul BieniaszInfluenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import.Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.Host and viral determinants for MxB restriction of HIV-1 infection.Structural insight into HIV-1 restriction by MxB.Contribution of MxB oligomerization to HIV-1 capsid binding and restrictionRole of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization SignalIdentification of Interferon-Stimulated Genes with Antiretroviral Activity.Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral ProteinsOligomerization Requirements for MX2-Mediated Suppression of HIV-1 InfectionSUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV.Accumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human PopulationsExpression levels of Fv1: effects on retroviral restriction specificities.The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.HIV suppression by host restriction factors and viral immune evasion.Peginterferon α-2a for the treatment of HIV infection.Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells.Mx oligomer: a novel capsid pattern sensor?Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production.Capsid-Dependent Host Factors in HIV-1 Infection.Role of Innate Genes in HIV Replication.Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.Differential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+CD4+ T cells.SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB.CryoEM structure of MxB reveals a novel oligomerization interface critical for HIV restriction.Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells.Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid.Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?Naturally occurring mutations in HIV-1 CRF01_AE capsid affect viral sensitivity to restriction factors.
P2860
Q26786870-3254446A-401B-4825-BE37-412645A73F51Q26801484-DB0BEACB-DDD4-4E52-9D6B-39C0A451FF09Q28551681-8FB0370A-511B-4096-B5D0-6DF8CB944F2CQ28606741-7628C433-2308-443D-AA0B-68C83CF6C8A9Q30385766-D3CD58EF-1422-4B32-A0EF-17F8E4AAFB86Q30400372-7829E3A0-E7CB-4C86-B011-A8B2EEA5E9ECQ34422979-94FF8A6C-07CA-4B13-ACA4-44FEA6A0055DQ34615762-BF07A6EB-12A8-407D-9F0B-675BBB8FA1D2Q35111033-1FA83078-E74B-4ADE-AD02-6AA8CEBDACACQ35608130-8B6B8C16-0283-47B2-937A-0C535D9CEA65Q35641044-17CDF952-3B98-4AED-95C8-A82CD895D017Q35914350-E831EAC5-F12D-4A82-9AE8-8BB20A6135B7Q36134164-D3994766-C19C-4CD7-8DDE-6DE957E90363Q36233912-31850C49-F502-417F-B26E-097901153676Q36433874-351A883C-E4A7-47F6-8AEE-48482B6F9F76Q36736438-5AE5831D-A4A2-4899-A06C-5A7DAD267111Q37034818-0CC83FC4-79C4-4EBD-8E93-ECF06C9CC672Q37037995-E43031D7-7FEA-4A6E-9D4A-247D1A7AC6BAQ37707466-B3A59757-E982-4145-885E-0A86BD183070Q38457723-6C80C902-2785-45F6-B4B3-689A3CF105A2Q38669306-D7295253-099D-4F7C-923B-2476DEBFE019Q38696747-44848C45-F201-4BED-AE4C-CEE4749D0861Q38765585-700EFA2F-7397-4F16-B87D-10428D6AFC19Q38789307-E33E1EFD-BFD5-4FDE-AAAA-2663543D2696Q38793701-4BC0503C-3258-40A2-B2CD-77344B92983AQ38807646-6EDEBAC8-DA88-4EF5-9AB0-59784AE985D2Q38834397-69303CC0-9412-40FD-8427-8BE5D77D5891Q38857308-B0BB72E0-5236-4B90-9926-C18A5B50563DQ39320682-11104468-1223-4B56-9E02-DB8837A0FF92Q39419975-9F3EE59E-D529-465D-84E1-645727DA8C9BQ39717911-C0E98F17-0B78-4729-90B2-37EB1C5BAE32Q40573003-3E1EFD8D-68E2-40B5-8875-3A8AE07A2A61Q40705574-9AC9F474-4205-4C3F-B5A1-22D93CD89902Q41555215-2266C00A-F32C-49CE-BB0A-D867BA2B1DA2Q41596393-C4580DA4-90BE-47EF-ADAD-8C0509E915B0Q41721059-C384D999-8AA3-4A06-9686-2C4B14203D2EQ42535705-AD231BC9-F490-4CA2-96A1-74C6A0429F9CQ47138132-8AE0287A-742D-4145-87C9-277C804FFDA4Q47146547-28D435ED-15DF-4E03-B755-52851DCA98F0Q47555067-208634D8-29BF-43B0-8856-F43D80272CF2
P2860
Host and viral determinants of Mx2 antiretroviral activity
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Host and viral determinants of Mx2 antiretroviral activity
@ast
Host and viral determinants of Mx2 antiretroviral activity
@en
type
label
Host and viral determinants of Mx2 antiretroviral activity
@ast
Host and viral determinants of Mx2 antiretroviral activity
@en
prefLabel
Host and viral determinants of Mx2 antiretroviral activity
@ast
Host and viral determinants of Mx2 antiretroviral activity
@en
P2093
P2860
P50
P356
P1433
P1476
Host and viral determinants of Mx2 antiretroviral activity
@en
P2093
Brian J Willett
Hannah F Preugschas
Melissa Kane
Paul D Bieniasz
Trinity M Zang
Victoria P Strouvelle
P2860
P304
P356
10.1128/JVI.00214-14
P577
2014-04-23T00:00:00Z